1Masktaller LL,Alpert JS.Atrial fibrillation review of mechanism etiology and therapy[J].Clin Cardiol,1997 ;20(7):640.
2Wolf PA,Abbott RD,Kannel WB,et al.Atrial fibrillation as an independent risk factor for stroke:the Framingham study[J].Stroke,1991; 22(8):983-8.
3Atrial fibrillation investigations risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation:analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994;154;1449-57.
5The use of oral anticoagulants (warfarin) in older people American Geriatrics Society guideline[J].J Am Geriatri Soci,2002 ;50:1439-45.
6Singer DE,Albers GW,Dalen JE,et al.Antithrombotic therapy in atrial fibrillation:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004 ;126(3 Suppl):s429-56.
7Gallus AS,Baker RI,Chong BH,et al.Consensus guidelines for warfarin therapy recommendation from the Austalasian society of thrombosis and heemestasis[J].MJA,2000; 172:600.
8Hirsh J,Fuster V,Ansell J,et al.American Heart Association/American college of cardiology foundation guide to warfarin therapy[J].J Am Coll Cardio1,2003 ;41:1633-52.
二级参考文献10
1Atrial Fibrillation Investigators.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials[].Archives of Internal Medicine.1994
2Wolf PA,Abbott RD,Kennel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study[].Stroke.1991
3Laupacis A,Albers G,Dalen J,et al.Antithrombotic therapy in atrial fibrillation.4th ACCP consensus conference on antithrombotic therapy[].Chest.1995
4EAFT Study Group.European atrial fibrillation trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and a recent transient ischemic attack or minor ischemic stroke[].The Lancet.1993
5Stroke Prevention in Atrial Fibrillation Investigators.Bleeding during antithrombotic therapy in patients with atrial fibrillation[].Archives of Internal Medicine.1996
6Hylek EM,Skates SJ,Sheehan MA,et al.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation[].The New England Journal of Medicine.1996
7Ezekowitz MD,Levine JA.Preventing stroke in patients with atrial fibrillation[].The Journal of The American Medical Association.1999
8Bjerkelund CJ,Orning OM.The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation[].The American Journal of Cardiology.1969
9Muramatsu H,Shimura T.Incidence of cerebral thromboembolic infarction associated with paroxysmal and persistent or permanent atrial fibrillation[].Journalism Assn of Community College.2000
10Manning WJ,Silverman DI,Keighley CS,et al.Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4. 5-year study[].Journalism Assn of Community College.1995
6Hirsh J, Fuster V, Ansell J, et al. American heart association/a meriean college of cardiology foundation guide to warfarin ther apy[J]. J Am Coll Cardiol, 2005,41 : 1 633-1 652.
7Olsson SB , Halperin JL . Prevention of stroke in patients with atrial fibrillation [J]. Sere in Vase Med,2005,5(3) :285-292.
